FDA-Drug2016-01-27Class II
Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
Pine Pharmaceuticals, LLC
Hazard
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Sold states
Nationwide and Puerto Rico
Affected count
N/A
Manufactured in
100 Colvin Woods Pkwy Suite 300, N/A, Tonawanda, NY, United States
Products
Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0584-2016Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief